Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients.
| Image |  |
|---|---|
| Description | scientific article published on 11 July 2017 |
| Author/s |
author: Christine M. Lovly |
| Publication date | July 11, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |